Featuring: BEAT’s financial outlook; a run-down of SRCL’s operations; HD’s sliding market position; DELL’s continued court-room banter; and SPPI’s.

CardioNet Inc. (Nasdaq: BEAT), Stericycle Inc. (Nasdaq: SRCL), Home Depot Inc. (NYSE: HD), Dell Inc. (Nasdaq: DELL) and Spectrum Pharmaceuticals Inc. (Nasdaq: SPPI).

CardioNet Inc. (Nasdaq: BEAT) Stock Alert – CardioNet Issues Downbeat Expectation Through 2011

Shares of heart monitor maker CardioNet Inc. (Nasdaq: BEAT) have been under pressure since late June amid speculation the company won’t be able to meet its aggressive expectations of revenue growth during the global slowdown.

In fact, late last week The Associated Press (AP) reported the Conshohocken, Pa.-based company said revenue derived from commercial health plans coverage of its wireless monitoring devices is growing less than expected, halving its 2009 profit guidance, cutting revenue estimates, and providing no guidance for 2010 and 2011.

The company now expects earnings to reach between 30 cents and 35 cents per share on revenue between $156 million and $160 million. Prior guidance was for earnings to reach 69 cents to 73 cents per share on revenue of between $170 million and $175 million. The AP said the revised estimate implies sales growth of 30% to 35%.

CardioNet previously said earnings would double next year on an increase of 50% in revenue. The company expected a profit of $2 per share in 2011, but now offers no guidance for 2010 and 2011.

The mean analysts’ estimate polled by Thomson Reuters was for CardioNet to earn 66 cents per share for 2009, $1.25 per share for 2010 and $1.85 per share in 2011, said AP.

Analyst Steven Halper of Thomas Weisel Partners said he expected CardioNet to revise downwardly its estimates, but anticipated the drop in revenue would come from Medicare reimbursements, not commercial carriers. Halper said the company’s expectations were too high, but believes the potential of the company remains high.

CardioNet’s revenue is derived from rates paid by health insurance carriers for the cost for implanting the company’s devices.

Halper has maintained his Market Weight rating, but analyst Matt Dolan of Roth Capital Partners downgraded CardioNet’s shares from Buy to Hold.

“We find its expected reimbursement levels to be too unpredictable to provide a clear overall revenue and earnings per share picture over the next couple of years, leaving little upside for the stock in the near-term,” he wrote, and sees substantial patient growth

CardioNet Inc. provides continuous, real-time ambulatory outpatient management solutions for monitoring relevant and timely clinical information regarding an individual’s health.

The company has developed an integrated patient monitoring platform that incorporates a wireless data transmission network, internally developed software, the United States Food and Drug Administration (FDA)-cleared algorithms and medical devices, and an around-the-clock digital monitoring service center.

Its initial efforts are focused on the diagnosis and monitoring of cardiac arrhythmias, or heart rhythm disorders, through its core Mobile Cardiac Outpatient Telemetry (MCOT), event and Holter services.

In its recent chart, BEAT is trading below its lower Bollinger Bands range, a bearish condition signaling that the stock is weak relative to the recent price action. MACD reflects a bearish signal, with the indicator trending below its 9-day moving average signal line, indicating downwardly trending moving averages.

Stericycle Inc. (Nasdaq: SRCL) Stock Alert

Stericycle Inc. (Nasdaq: SRCL) provides business and consulting services to more than 420,000 customers worldwide. The company’s focus is on helping them promote safety, improve regulatory compliance and manage risk. Based in Lake Forest, Illinois, the company operates in the US, United Kingdom, Ireland, Canada, Mexico, Argentina and Chile.

Stericycle’s national networks include a total of 89 processing or combined processing and collection sites, and 97 additional transfer, collection or combined transfer and collection sites. Stericycle’s regulated waste processing technologies include autoclaving, its own electro-thermal-deactivation system (ETD), chemical treatment and incineration.

During the year ended December 31, 2008, the company completed 22 acquisitions, of which 12 were domestic regulated waste businesses, two were domestic return management businesses and eight were international regulated waste businesses in Canada, Latin America and Europe.

The company has scheduled its earnings conference call for Tuesday, July 28, 2009, at 5 p.m. ET.

In its recent chart, SRCL is trading at its lower Bollinger Bands range, a bearish condition signaling that the stock is weak relative to the recent price action. MACD reflects a bullish signal, with the indicator trending above its 9-day moving average signal line, indicating upwardly trending moving averages.

Home Depot Inc. (NYSE: HD) Stock Alert – Home Depot Drops to No. 4 Retailer

The once No.2 retailer Home Depot Inc. (NYSE: HD) has dropped to the No. 4 spot, according to the retail magazine Store and the National Retail Federation.

Sales at the Atlanta-based Home Depot dropped 7.8% in 2008 to $71.3 billion, pushing it behind the king of retail Wal-Mart, the now No. 2 grocery chain Kroger, and bulk retailer Costco at No.3, The Atlanta Journal-Constitution said in a recent article.

The shake-up in ranking reflects the recessionary effects on consumer behavior to basic necessities of food and away from discretionary purchases.

Robert Rulla, analyst for Fitch told Stores magazine said with “credit markets still tight, the prospects for home improvement spending, at least through 2009, remain challenging.”

Home Depot is a home improvement retailer. Home Depot stores sell an assortment of building materials, home improvement and lawn and garden products, and provide a number of services. Stores average approximately 105,000 square feet of enclosed space, with approximately 24,000 additional square feet of outside garden area.

During the fiscal year ended February 1, 2009 (fiscal 2008), the company had 2,233 Home Depot stores located throughout the United States, including the Commonwealth of Puerto Rico and the territories of the United States Virgin Islands and Guam, Canada, China and Mexico.

On January 26, 2009, the company announced the closing of its EXPO, THD Design Center and Yardbirds stores.

In its recent chart, HD is trading at its lower Bollinger Bands range, a bearish condition signaling that the stock is weak relative to the recent price action. MACD reflects a bullish signal, with the indicator trending above its 9-day moving average signal line, indicating upwardly trending moving averages.

Dell Inc. (Nasdaq: DELL) Stock Alert - Second Federal Judge Sides with Former IBM Executive Johnson; Johnson’s Lawyer Recommends Client to Start Work with Dell

For a second time in a week a federal judge has ruled in favor of former IBM M&A executive David Johnson. The decision his lawyer says allows Johnson to become “fully engaged” at his new employer, Dell Inc. (Nasdaq: DELL).

IBM brought suit against Johnson alleging he broke a non-compete agreement when he agreed to work for Dell, taking with him trade secrets that may help Dell and hurt IBM.

Johnson had been with IBM for 27 years and disputes the company’s contentions that he possesses meaningful trade secrets, while also claiming IBM exaggerates its complaint against him.

The case brought against Johnson, personally, continues, however, after judge Stephen Robinson of U.S. District Court for Southern District of New York wrote that IBM raised pertinent questions regarding the circumstances of Johnson’s move to Dell.

IBM also claims Johnson acted irresponsible with the company’s resources when he started a venture capital firm.

Although full resolution to lawsuits against Johnson remain less murky, Johnson’s lawyer Michael Banks said, recommending to his client that he can now “begin to work fully for Dell.”

Some analyst say IBM’s persistence in its attempted blocks against Johnson’s move to Dell underscores the value he brought to IBM which is now going to competitor Dell.

Dell is a technology company that designs, develops, manufactures, markets, sells and supports a range of products. Its product categories include mobility products, desktop personal computers (PCs), software and peripherals, servers and networking, services and storage.

The company manages its business in four operating segments: Americas Commercial; Europe, Middle East and Africa (EMEA) Commercial; Asia Pacific-Japan (APJ) Commercial, and Global Consumer. During the fiscal year ended January 30, 2009 (fiscal 2009), the company acquired the Networked Storage Company.

In April 2008, the company completed the acquisition of MessageOne Inc., a company engaged in providing software-as-a-service (SaaS)-enabled, enterprise-class, e-mail business continuity, compliance, archiving and disaster recovery services.

In January 2009, the company acquired the Microsoft IT consulting and solutions segments of Allin Corp..

In its recent chart, DELL is trading at its lower Bollinger Bands range, a bearish condition signaling that the stock is weak relative to the recent price action. MACD reflects a bullish signal, with the indicator trending above its 9-day moving average signal line, indicating upwardly trending moving averages.

Spectrum Pharmaceuticals Inc. (Nasdaq: SPPI) Stock Alert – Spectrum Pharmaceuticals to Issue 2.9M Shares

Spectrum Pharmaceuticals Inc. (Nasdaq: SPPI), a biotechnology company focused on the field of oncology, said it has secured commitments from institutional investors to purchase $21 million of its common stock in a registered direct offering, according to company news release.

The Irvine-Calif.-based company said it expects to receive $20 million in proceeds from the sale after agents fees and other expenses.

Details of the agreement include the sale of 2,936,037 shares of common shares and warrants to purchase a half of one share at $7.1525. The warrants can be exercised at $7.10 per share beginning six months after issuance and will expire 90 days after the first date the warrants are exercizable.

The company said the proceeds will be used for general corporate purposes. The offering is expected to close no later than July 6, 2009.

Spectrum Pharmaceuticals is a commercial stage biopharmaceutical company, engaged in developing and commercializing therapies with a focus primarily in the areas of hematology-oncology and urology. The company’s product is apaziquone (formerly EOquin), which is in two phase 3 clinical trials for non-muscle invasive bladder cancer under a collaboration with Allergan Inc. Another drug, ozarelix is in a phase 2 clinical trial for benign prostatic hypertrophy (BPH).

On December 15, 2008, Spectrum and Cell Therapeutics Inc. (CTI) partnered to form a joint venture, RIT Oncology, LLC (RIT), to develop Zevalin ([90Y]-ibritumomab tiuxetan) in the United States. Its subsidiaries include OncoRx Pharma Private Limited, Spectrum Pharmaceuticals GmbH, RIT Oncology, LLC and Spectrum Pharma Canada.

During the year ended December 31, 2008, the company dissolved NeoJB LLC.

In its recent chart, SPPI is trading at its higher Bollinger Bands range, a bullish condition signaling that the stock is strong relative to the recent price action. MACD reflects a bullish signal, with the indicator trending above its 9-day moving average signal line, indicating upwardly trending moving averages.

InvestorSoup.com Research Disclosure

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEB SITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.

The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

Our newsletter and Web site have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company. An individual should never invest in the securities of any of the companies profiled based solely on information contained in our report. Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research.

Any individual who chooses to invest in any securities should do so with caution. Investing in securities is speculative and carries a high degree of risk; you may lose some or all of the money that is invested. Always research your own investments and consult with a registered investment advisor or licensed stock broker before investing.

InvestorSoup.com is a Web site wholly owned by BlueWave Advisors, LLC. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. BlueWave Advisors LLC, its principal and/or its affiliates will hold positions in the company profiled and may buy or sell securities at any time without notice.

Information contained in our report will contain “forward looking statements” as defined under Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Subscribers are cautioned not to place undue reliance upon these forward looking statements. These forward looking statements are subject to a number of known and unknown risks and uncertainties outside of our control that could cause actual operations or results to differ materially from those anticipated. Factors that could affect performance include, but are not limited to, those factors that are discussed in each profiled company’s most recent reports or registration statements filed with the SEC. You should consider these factors in evaluating the forward looking statements included in the report and not place undue reliance upon such statements.

We are committed to providing factual information on the companies that are profiled. However, we do not provide any assurance as to the accuracy or completeness of the information provided, including information regarding a profiled company’s plans or ability to effect any planned or proposed actions. We have no first-hand knowledge of any profiled company’s operations and therefore cannot comment on their capabilities, intent, resources, nor experience and we make no attempt to do so. Statistical information, dollar amounts, and market size data was provided by the subject company and related sources which we believe to be reliable.

To the fullest extent of the law, we will not be liable to any person or entity for the quality, accuracy, completeness, reliability, or timeliness of the information provided in the report, or for any direct, indirect, consequential, incidental, special or punitive damages that may arise out of the use of information we provide to any person or entity (including, but not limited to, lost profits, loss of opportunities, trading losses, and damages that may result from any inaccuracy or incompleteness of this information).

We encourage you to invest carefully and read investment information available at the Web sites of the SEC at http://www.sec.gov and FINRA at http://www.finra.org.